Expenditure on chronic disease has exploded to almost three-quarters of US health care spending in the last decade, leaving our health care system in danger of collapse. We are paying the price of a short-term focus on disease treatment rather than preventative approaches to chronic illness.
Even our best preventative attempts seem to be based on one-size-fits-all therapeutic regimens. Fortunately, increased know-how and emerging technologies around genomics, proteomics, metabolomics, and bioinformatics make it possible to define different phenotypes associated with what were once considered single, nominal conditions. How long will it be before we translate that information and advanced diagnostic test results into a personalized, predictive and preventative approach to individual patient care?
We at Proventys have been observing medical trends closely. We know that the diagnostic tests currently available, coupled with accurate prospective study data and advanced analytics, can open the doorway to tomorrow's practice of prospective medicine. We call it prospective medicine because it is based on individualized health planning rather than reactive treatment of disease. Personalized Medicine offers every individual the prospect of a better quality of life and greater value health care through personalized, predictive and preventative medicine.
Read more about prospective medicine.
